| Baricitinib plus remdesivir for hospitalized adults with Covid-19 AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... New England Journal of Medicine 384 (9), 795-807, 2021 | 1757 | 2021 |
| Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... The lancet respiratory medicine 9 (12), 1365-1376, 2021 | 140 | 2021 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 87 | 2022 |
| Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, N Gentile, S Collins, ... Jama 328 (16), 1595-1603, 2022 | 63 | 2022 |
| ACTT-2 Study Group Members AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ... Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J …, 2021 | 59 | 2021 |
| Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: a randomized clinical trial S Naggie, DR Boulware, CJ Lindsell, TG Stewart, AJ Slandzicki, SC Lim, ... JAMA 329 (11), 888-897, 2023 | 41 | 2023 |
| High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa EM Etta, L Mavhandu, C Manhaeve, K McGonigle, P Jackson, D Rekosh, ... AIDS research and therapy 14, 1-12, 2017 | 41 | 2017 |
| Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial MW McCarthy, S Naggie, DR Boulware, CJ Lindsell, TG Stewart, ... JAMA 329 (4), 296-305, 2023 | 39 | 2023 |
| Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests P Liu, P Jackson, N Shaw, S Heysell AIDS research and therapy 13, 1-5, 2016 | 39 | 2016 |
| Rev–RRE functional activity differs substantially among primary HIV-1 isolates PE Jackson, DM Tebit, D Rekosh, ML Hammarskjold AIDS research and human retroviruses 32 (9), 923-934, 2016 | 26 | 2016 |
| Safety and efficacy of dupilumab for the treatment of hospitalized patients with moderate to severe coronavirus disease 2019: a phase 2a trial J Sasson, AN Donlan, JZ Ma, HM Haughey, R Coleman, U Nayak, ... Open Forum Infectious Diseases 9 (8), ofac343, 2022 | 22 | 2022 |
| Evolution of the HIV-1 rev response element during natural infection reveals nucleotide changes that correlate with altered structure and increased activity over time C Sherpa, PEH Jackson, LR Gray, K Anastos, SFJ Le Grice, ... Journal of virology 93 (11), 10.1128/jvi. 02102-18, 2019 | 17 | 2019 |
| Renin-angiotensin system modulation with synthetic angiotensin (1-7) and angiotensin II type 1 receptor–biased ligand in adults with COVID-19: two randomized clinical trials WH Self, MS Shotwell, KW Gibbs, M De Wit, DC Files, M Harkins, ... Jama 329 (14), 1170-1182, 2023 | 15 | 2023 |
| ACTT-3 study group members. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised … AC Kalil, AK Mehta, TF Patterson, N Erdmann, CA Gomez, MK Jain, ... Lancet Respir Med 9 (12), 1365-1376, 2021 | 14 | 2021 |
| Sequence and functional variation in the HIV-1 Rev regulatory axis PEH Jackson, G Dzhivhuho, D Rekosh, ML Hammarskjold Current HIV research 18 (2), 85-98, 2020 | 12 | 2020 |
| HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA LR Gray, RE Jackson, PEH Jackson, S Bekiranov, D Rekosh, ... Retrovirology 16, 1-17, 2019 | 12 | 2019 |
| Opportunities to increase rates of parent improvement in Australian sugarcane breeding programs. AR Rattey, P Jackson, X Wei, M Cox, J Stringer 2004 Conference of the Australian Society of Sugar Cane Technologists held …, 2004 | 9 | 2004 |
| Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: The ACTIV-6 randomized clinical trial TG Stewart, PA Rebolledo, A Mourad, CJ Lindsell, DR Boulware, ... JAMA 330 (24), 2354-2363, 2023 | 8 | 2023 |
| Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19 B Zhu, X Wei, H Narasimhan, W Qian, R Zhang, IS Cheon, Y Wu, C Li, ... Science Immunology 8 (82), eadf0348, 2023 | 8 | 2023 |
| A novel retroviral vector system to analyze expression from mRNA with retained introns using fluorescent proteins and flow cytometry PEH Jackson, J Huang, M Sharma, SK Rasmussen, ML Hammarskjold, ... Scientific reports 9 (1), 6467, 2019 | 6 | 2019 |
